Lung Cancer Feature | Upcoming Radio Broadcasts
When compared to other cancers, lung cancer is seemingly unknown. It is often associated with smoking and considered to be very deadly, but few people know anything further than that about the disease.
Lung cancer is the number one cancer killer, killing more than 160,000 people in the United States alone each year. That is equal to the population of Dayton, OH, killed each year by this deadly disease . Despite this, in the United States, lung cancer receives just $1,200 of federal funding per death, while breast cancer receives more than $27,000 per death, followed by $14,000 for prostate cancer and $6,500 for colon cancer.
That is why we at Oncimmune value raising more awareness for lung cancer – and why we are excited to share with you a couple of our most recent lung cancer awareness campaigns.
In a recent interview with “It’s Your Health Network”, Greg Stanley - author of the Hello Have You Heard blog - discusses lung cancer, lung cancer symptoms, early lung cancer detection, and EarlyCDT®-Lung, a blood test which aids in the early detection of lung cancer.
The segment will air on the following stations at the upcoming times:
Monday August 6th:
WERL AM 950 Freedom Talk in Eagle Rock, Wisconsin www.werlam.com
Every Monday-Friday from 11:00pm-12:00am CT and 10:00-11:00am CT on Saturdays
WATW AM 1400 Freedom Talk in Ashland, Wisconsin www.watwam.com
Every Monday-Friday from 11:00pm-12:00am CT
WPFP AM 980 Freedom Talk Park Falls, Wisconsin www.watwam.com
Every Monday-Friday from 11:00pm-12:00am CT
WFER AM 1230 Freedom Talk in Iron River Michigan, www.wferam.com
Every Monday-Friday from 11:00pm-12:00am CT
Thursday, August 9th:
WUML, 91.5 FM Public Radio in Greater Boston
Every Thursday from 9:30-10:30am ET
You can listen on-line by going to www.itsyourhealthnetwork.com
Sunday, August 12th:
NPR affiliate KMBH, Public Radio 88 FM - http://www.kmbh.org
Every Sunday at noon
The blood test, EarlyCDT-Lung, can potentially detect lung cancer before symptoms are evident – when the cancer is pea-size or smaller. When treated at a small size, five-year survival rates are more than 50%. Currently, about 85% of lung cancers are found at a “golf-ball” size or larger when the overall 5-year survival rate is 16%.
EarlyCDT-Lung is doctor-prescribed. The free test kit will be mailed to your home. Take the kit to your physician for a blood draw. Results will be sent to your physician in 10 days. The test is covered by private health insurance and Medicare Part B.
EarlyCDT-Lung is intended for anyone who is 40-75 yrs old with 1 or more of these lung cancer factors:
- Long-term smoker or former smoker
- Extensive secondhand smoke exposure
- Family history
- Exposure to radon, asbestos, coal, etc.
The test is not intended for patients who have previously had cancer.
To find out more about EarlyCDT-Lung, click here or contact Oncimmune’s Client Services team at 1-888-583-9030 or by emailing clientservices@oncimmune.com.
According to data from the National Cancer Institute, the average five-year survival rate for a lung cancer patient is only 16%. If the cancer is caught in the later stages, after it has spread, that number can drop all the way down to 4%.
The key to fighting lung cancer is catching the disease in its earliest stages, when the five-year survival rate jumps to more than 50% and some studies have shown the 5-year survival as high as 90% if caught in stage 1.
Talk about the symptoms with your loved ones and take action in discovering lung cancer when it’s in its earliest stages, and the survival rates are higher. The more you know about the symptoms of lung cancer, the better prepared you and your loved ones will be.
To learn more about Oncimmune’s EarlyCDT-Lung, the blood test to aid in the early detection of lung cancer, please visit www.HelloHaveYouHeard.com. The test is covered by Medicare Part B and all private insurance companies (Blue Cross and Blue Shield, Aetna, etc.). Since its commercial release in 2009, it has helped find numerous lung cancer cases, and is currently being used by over a thousand doctors across the United States.
